SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000863894-21-000013
Filing Date
2021-12-02
Accepted
2021-12-02 12:22:09
Documents
98
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-K veru-20210930x10k.htm   iXBRL 10-K 4152104
2 EX-4.3 veru-20210930xex4_3.htm EX-4.3 32917
3 EX-21 veru-20210930xex21.htm EX-21 6834
4 EX-23.1 veru-20210930xex23_1.htm EX-23.1 4188
5 EX-31.1 veru-20210930xex31_1.htm EX-31.1 15195
6 EX-31.2 veru-20210930xex31_2.htm EX-31.2 15106
7 EX-32.1 veru-20210930xex32_1.htm EX-32.1 11141
  Complete submission text file 0000863894-21-000013.txt   9954804

Data Files

Seq Description Document Type Size
8 EX-101.SCH veru-20210930.xsd EX-101.SCH 77208
9 EX-101.CAL veru-20210930_cal.xml EX-101.CAL 98367
10 EX-101.DEF veru-20210930_def.xml EX-101.DEF 291801
11 EX-101.LAB veru-20210930_lab.xml EX-101.LAB 617464
12 EX-101.PRE veru-20210930_pre.xml EX-101.PRE 536869
13 EXTRACTED XBRL INSTANCE DOCUMENT veru-20210930x10k_htm.xml XML 530711
Mailing Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127
Business Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-13602 | Film No.: 211465595
SIC: 2834 Pharmaceutical Preparations